Biofrontera Inc. (NASDAQ:BFRIW – Get Free Report) was the target of a large increase in short interest in August. As of August 31st, there was short interest totaling 5,274 shares, an increase of 77.3% from the August 15th total of 2,975 shares. Based on an average daily volume of 2,250 shares, the days-to-cover ratio is presently 2.3 days.
Biofrontera Stock Performance
Shares of NASDAQ BFRIW remained flat at $0.02 during midday trading on Wednesday. 264 shares of the stock traded hands, compared to its average volume of 5,962. The firm’s 50 day moving average is $0.03 and its 200 day moving average is $0.03. Biofrontera has a 52-week low of $0.02 and a 52-week high of $0.15.
Biofrontera Company Profile
Biofrontera AG is a biopharmaceutical company headquartered in Leverkusen, Germany, specializing in the development, manufacture and commercialization of dermatology products. Founded in 1997, the company focuses on therapies for skin diseases through innovative drug and device combinations. Its core business centers on photodynamic therapy, where a photosensitizing agent is activated by a specialized light source to treat precancerous and cancerous skin conditions.
The company’s flagship product, Ameluz, is a topical formulation of aminolevulinic acid used in conjunction with the BF-RhodoLED irradiation device.
Featured Stories
- Five stocks we like better than Biofrontera
- Micron’s AI Memory Boom Could Send Shares 100% Higher
- Apple Stock Surges After Its Biggest Product Launch in Years—Can It Last?
- The Ultimate Cyber Shield: CrowdStrike Rises Past $235
- Palantir Just Told Wall Street Where AI Infrastructure Is Headed
Receive News & Ratings for Biofrontera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biofrontera and related companies with MarketBeat.com's FREE daily email newsletter.
